Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy

Cancer Immunology, Immunotherapy

Volumn 52, Issue 1, 2003, Pages 53-58

  Norris, Suzanne ^a   Doherty, Derek G ^a,b   Curry, Michael ^a   McEntee, Gerry ^a   Traynor, Oscar ^a   Hegarty, John E ^a   O'Farrelly, Cliona ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Hepatic malignancy; Human; Natural killer cell; T cell

Indexed keywords

CD94 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LYMPHOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOSTIMULATION; LIVER CANCER; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR REJECTION;

EID: 0037268349     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0331-1     Document Type: Article

References (34)

1. Bendelac A (1997) Mouse CD1-specific NK1 T cells - development, specificity, and function. Annu Rev Immunol 15:535
2. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 159:2240
3. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M (1997) Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumours. Science 278:1623
4. Curry M, Norris S, Golden-Mason L, Doherty DG, McEntee G, Traynor O, Hegarty JE, O'Farrelly C (2000) Isolation of hepatic lymphocytes from adult human liver suitable for phenotypic and functional characterisation. J Immunol Methods 242:21
5. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, O'Farrelly C (1999) The human liver contains multiple populations of NK cells, T cells, and natural T cells with distinct cytotoxic activities and Th1, Th2 and Th0 cytokine secretion patterns. J Immunol 161:3527
6. Doherty DG, O'Farrelly C (2000) Innate and adaptive lymphoid cells in the human liver. Immunol Rev 174:5
7. Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingiri MC, Moretta L (1994) T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 24:2294
8. Godfrey DI, Hammond KJL, Poulton LD, Smyth MJ, Baxter AG (2000) NKT cells: facts, functions and fallacies. Immunol Today 21:573
9. Hata K, Van Thiel D, Herberman RB, Whiteside T (1991) Natural killer activity of human-derived lymphocytes in various liver disease. Hepatology 14:495
10. + T cells is controlled by T-cell receptor engagement. Nature 403:325
11. Ikeda H, Lethe B, Lehmann F, Van Baren N, Baurain J-F, De Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG (1997) Characterisation of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory, receptor. Immunity 6:199
12. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675
13. Kurosawa S, Harada M, Matsuzaki G, Shinomiya Y, Terao H, Kobayashi N, Nomoto K (1995) Early-appearing tumor-infiltrating natural killer cells play a crucial role in the generations of anti-tumour T lymphocytes. Immunology 85:338
14. Lanier LL, Corliss B, Phillips JH (1997) Arousal and inhibition of human NK cells. Immunol Rev 155:145
15. Lanier LL (1998) Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 92:705
16. Lanier LL (2001) On guard - activating NK receptors. Nature Immunol 2:23
17. Ljungren HG, Karre K (1998) In search of the "missing self": MHC molecules and NK recognition. Immunol Today 11:237
18. + cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 153:1617
19. Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE (2000) Immune suppression and skin cancer development: regulation by NKT cells. Nature Immunol 1:521
20. Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A, Mingiri MC, Moretta L (1997) Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 155:105
21. Norris S, Doherty DG, Collins C, McEntee G, Traynor O, Hegarty J, O'Farrelly C (1999) Natural T cells in the normal human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells. Hum Immunol 60:20
22. + cells in the liver of mice. J Exp Med 180:699
23. 2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc Natl Acad Sci USA 94:13140
24. Satoh M, Seki S, Hashimoto W, Ogasawara K, Kobayashi T, Kumagai K, Matsuno S (1996) Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol 157:3886
25. + T cells in T helper 1 immune responses. Immunol Rev 174:35
26. Smyth MJ, Thia KYT, Street SEA, Cretney E, Trapani JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661
27. Smyth MJ, Taniguchi M, Street SEA (2000) The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 165:2665
28. Sonoda K-H, Faunce DE, Taniguchi M, Exley M, Balk S, Stein-Streilein J (2001) NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 166:42
29. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumour metastasis. J Immunol 156:3366
30. + T cells in patients with malignancy. Clin Exp Imunol 97:522
31. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Berzofsky JA (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunol 1:515
32. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P (1997). Human diversity in killer cell inhibitory receptor genes. Immunity 7:753
33. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P (1997) Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7:739
34. Winnock M, Garcia-Barcina M, Huet S, Bernard P, Saric J, Biolac-Sage P, Gualde N (1993) Functional characterisation of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology 105:1152